Acute mental disturbance caused by synthetic cannabinoid: A potential emerging substance of abuse in Hong Kong

East Asian Archives of Psychiatry

Volumn 22, Issue 1, 2012, Pages 31-33

  Tung, Chi Kwong ^a   Chiang, T P ^a   Lam, M ^a  

^a CASTLE PEAK HOSPITAL   (Hong Kong)

Author keywords

Cannabinoids; Designer drugs; Substance related disorders

Indexed keywords

CANNABINOID; CANNABIS; MIDAZOLAM; PERPHENAZINE;

ACUTE MENTAL DISTURBANCE; ACUTE PSYCHOSIS; ADULT; ARTICLE; AUDITORY HALLUCINATION; CANNABIS ADDICTION; CASE REPORT; DELUSION; DISEASE SEVERITY; DRUG DEPENDENCE; HONG KONG; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADULT; ANTIPSYCHOTIC AGENTS; CANNABINOIDS; HUMANS; MALE; MEDICATION ADHERENCE; PSYCHOSES, SUBSTANCE-INDUCED; REMISSION, SPONTANEOUS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84859487811     PISSN: 20789947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Psychonaut Web Mapping Research Group. Spice report; 2009. Website: www.psychonautproject.eu/documents/reports/Spice.pdf. Accessed 1 Oct 2011.
2. Steup C. Untersuchung des Handelsproduktes Spice [in German]. Website: http://usualredant.de/drogen/download/analyse-the-pharmspice-jwh-018.pdf. Accessed 1 Oct 2011.
3. European Monitoring Centre for Drugs and Drug Addiction. Drug profile: synthetic cannabinoids and 'spice'; 2009. Website: http://www.emcdda.europa.eu/ publications/drug-profiles/synthetic-cannabinoids. Accessed 1 Oct 2011.
4. Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, et al. Spice: a never ending story? Forensic Sci Int 2009;191:58-63.
5. Atwood BK, Huffman J, Straiker A, Mackie K. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol 2010;160:585-93.
6. Atwood BK, Lee D, Straiker A, Widlanski TS, Mackie K. CP47.497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists. Eur J Pharmacol 2011;659:139-45.
7. Müller H, Sperling W, Köhrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res 2010;118:309-10.
8. Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Dtsch Arztebl Int 2009;106:464-7.
9. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 2009;44:832-7.
10. Schneir AB, Cullen J, Ly BT. "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med 2011;40:296-9.
11. Every-Palmer S. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend 2011;117:152-7.
12. Zweiundzwanzigste Verordnung. Zur Änderung betä ubungsmittelrechtlicher Vorschriften [in German]. Bundesgesetzblatt Jahrgang 2009 Teil I Nr.3, ausgegeben zu Bonn am 21. Januar 2009.
13. Legislative Council Brief. Dangerous Drugs Ordinance Chapter 134 (Amendment of First Schedule) Order 2011. Hong Kong: 2011. Website: http://www.legco.gov.hk/yr10-11/english/subleg/brief/7-brf.pdf. Accessed 1 Oct 2011.
14. Dargan PI, Hudson S, Ramsey J, Wood DM. The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'. Int J Drug Policy 2011;22:274-7.
15. Hammersley R. Dangers of banning spice and the synthetic cannabinoid agonists. Addiction 2010;105:373.
16. Möller I, Wintermeyer A, Bender K, Jübner M, Thomas A, Krug O, et al. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test Anal 2010;3:609-20.
17. Dowling G, Regan L. A method for CP 47, 497 a synthetic nontraditional cannabinoid in human urine using liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:253-9.